Lysophosphatidylcholine increases vascular superoxide anion production via protein kinase C activation

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 14, Issue 6, 1994, Pages 1007-1013

  Ohara, Yuichi ^a   Peterson, Timothy E ^a   Zheng, Bin ^a   Kuo, J F ^a   Harrison, David G ^a,b,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

Endothelium dependent vascular relaxation; Lysophosphatidylcholine; Protein kinase C; Protein phosphorylation; Rabbit aorta; Superoxide anion

Indexed keywords

CALPHOSTIN C; ENDOTHELIUM DERIVED RELAXING FACTOR; LYSOPHOSPHATIDYLCHOLINE; PHORBOL 12 ACETATE 13 MYRISTATE; PROTEIN KINASE C; SUPEROXIDE;

ANIMAL TISSUE; AORTA; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RABBIT;

ANIMAL; AORTA; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; LYSOPHOSPHATIDYLCHOLINES; POLYCYCLIC HYDROCARBONS; PROTEIN KINASE C; RABBITS; SUPEROXIDES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028179535     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.14.6.1007     Document Type: Article

References (21)

1. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modification of low-density lipoproteins that increase its atherogenicity. N Engl J Med. 1989;320:915-924.
2. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogencsis. J Clin Invest. 1991;88:1785-1792.
3. Carew TE, Schwenke DC, Steinberg D. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidant in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks slowing the progression of atherosclerosis in the WHHL rabbit. Proc Natl Acad Sci USA. 1987;84:7725-7729.
4. Palinski W, Rosenfeld ME, Ylä-Herttuala S, Gurtner GC, Socher SS, Butler SW, Parthasarathy S, Steinberg D. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A. 1989;86:1372-1380.
5. 2 activity in endothelial cell-induced modification of low density lipoprotein. Proc Natl Acad Sci USA. 1985;82:3000-3004.
6. Yokoyama M, Hirata K, Miyake R, Akita H, Ishikawa Y, Fukuzaki H. Lysophosphatidylcholine: essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein. Biochem Biophys Res Commun. 1990;168:301-308.
7. Portman OW, Alexander M. Lysophosphatidylcholine concentrations and metabolism in aortic intima plus inner media: effect of nutritionally induced atherosclerosis. J Lipid Res. 1969;10:158-165.
8. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature. 1990;44: 160-162.
9. Quinn MT, Parthasarathy S, Steinberg D. Lysophosphatidyl-choline: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc Natl Acad Sci USA. 1988;85: 2805-2809.
10. Kume N, Cybulsky MI, Gimbrone MA Jr. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest. 1992;90:1138-1144.
11. Inoue N, Hirata K, Yamada M, Hamamori Y, Matsuda Y, Akita H, Yokoyama M. Lysophosphatidylcholine inhibits bradykinin-induced phosphoinositide hydrolysis and calcium transients in cultured bovine aortic endothelial cells. Cire Res. 1992;71: 1410-1421.
12. Kugiyama K, Ohgushi M, Sugiyarha S, Murohara T, Fukunaga K, Miyamoto E, Yasue H. Lysophosphatidylcholine inhibits surface receptor-mediated intracellular signals in endothelial cells by a pathway involving protein kinase C activation. Circ Res. 1992;71: 1422-1428.
13. Oishi K, Raynor RL, Charp PA, Kuo JF. Regulation of protein kinase C by lysophospholipids: potential role in signal transduction. J Biol Chem. 1988;263:6865-6871.
14. Nishizuka Y. Studies and perspectives of protein kinase C. Science. 1986;233:305-312.
15. Nishizuka Y. The molecular heterogeneity of protein kinase C and its implications of cellular regulation. Nature. 1988;334:661-665.
16. Drexler HG, Jansscn JW, Brenner MK, Hoffbrand AV, Bartram CR. Rapid expression of protooncogenes c-fos and c-myc in B-chronic lymphocytic leukemia cells during ditfferentiation induced by phorbol ester and calcium ionophore. Blood. 1989;73: 1656-1663.
17. Consigny PM. Phorbol amplification of serotonin-induced arterial contractions is endothelium dependent. Am J Physiol. 1989; 251(Heart Circ Physiol 26):H1174-H1179.
18. 2-containing soluble immune complexes. Immunology. 1983;48: 657-665.
19. Matsubara T, Ziff M. Superoxide anion release by human endothclial cells: synergism between a phorbol ester and a calcium ionophore. J Cell Physiol. 1986;127:207-210.
20. 5a and TNF-α: divergent signal transduction pathways. Am J Physiol. 1992;263(Lung Cell Mol Physiol 7):L51-L59.
21. Steinbrecher UP. Role of superoxide in endothelial-cell modification of low density lipoproteins. Biochem Biophys Acta. 1986;959: 20-30.